Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

about

Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.

Item

http://www.wikidata.org/entity/Q54967868

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Association Between Promoter P ...... Donors and Transplant Outcome.

@en

Association Between Promoter P ...... Donors and Transplant Outcome.

@nl

type

Item

label

Association Between Promoter P ...... Donors and Transplant Outcome.

@en

Association Between Promoter P ...... Donors and Transplant Outcome.

@nl

prefLabel

Association Between Promoter P ...... Donors and Transplant Outcome.

@en

Association Between Promoter P ...... Donors and Transplant Outcome.

@nl

P1476

Association Between Promoter P ...... Donors and Transplant Outcome.

@en

P2093

Arjan D van Zuilen

http://www.w3.org/2001/XMLSchema#string

Henny G Otten

http://www.w3.org/2001/XMLSchema#string

Tineke Kardol-Hoefnagel

http://www.w3.org/2001/XMLSchema#string

P2860

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

A global reference for human genetic variation

The complotype: dictating risk for inflammation and infection

Membrane attack by complement: the assembly and biology of terminal complement complexes

Host genetic determinants of influenza pathogenicity.

OPTN/SRTR 2012 Annual Data Report: kidney.

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

Complement regulators and inhibitory proteins.

Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.

Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.

P304

972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.00972

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marianne C. Verhaar

Laura A Michielsen

P577

2018-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29867953

http://www.w3.org/2001/XMLSchema#string

P932

5960667

http://www.w3.org/2001/XMLSchema#string